![]() | |
Names | |
---|---|
IUPAC name 3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide | |
Identifiers | |
ECHA InfoCard | 100.209.922 |
PubChem CID | |
CompTox Dashboard (EPA) | |
Properties | |
C18H19N3O2S | |
Molar mass | 341.43 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
VU-0152100 is a positive modulator of the M4 receptor, [1] one of the muscarinic acetylcholine receptors.
In mice, VU-0152100 is able to decrease self-administration of cocaine, this is thought to come from the M4 receptor's action on D1 containing dopaminergic neurons. [2] It is also able to almost completely inhibit the hyperactivity caused by cocaine. [3] Another study has shown that this drug is able to reverse hyperlocomotion induced by amphetamine, in an anti-psychotic-like manner. [4] This data suggests that it could potentially be developed as a treatment for stimulant abuse.